Fundz

Omnio raises €2.9 million to advance its plasminogen-based therapy for chronic wounds. This funding round was oversubscribed and led by existing investors.

PRIVATEOct 02, 2026

Amount Raised

€2.9 Million

Round Type

Seed

UmeåBiotechnologyHealth CareMedicalTherapeutics

Description

Omnio, a Umeå-based BioTech startup, has successfully raised €2.9 million from existing investors to advance its plasminogen-based therapy for hard-to-heal chronic wounds. The funds will help move the therapy closer to clinical studies. This follows a previous €4.3 million financing round to complete its GMP manufacturing process. The CEO expressed confidence in continued investor support for development.

Company Information

Company

Omnio

Location

Umeå, Vasterbottens Lan, Sweden

About

Omnio is a Umeå-based BioTech startup developing plasminogen-based therapies for chronic wounds and related conditions. Founded on research by Professor Tor Ny, the company is focused on addressing impaired wound healing, particularly in diabetic foot ulcers. Its lead drug candidate is a recombinant form of plasminogen aimed at helping patients regain mobility and avoid amputation. The company is scaling up manufacturing and preparing for clinical studies.

Fundz sees it the moment Omnio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Omnio's next move

See what Strategic adds

Omnio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.